-
Apr 26, 2013 08:03AM
Jefferies Lifts Numbers on Biogen (BIIB) Post Q1
-
Mar 28, 2013 09:27AM
StreetInsider.com Pre-Open Movers 03/28: (RPRX) (DECK) (XONE) Higher; (FIVE) (RHT) (GME) Lower (more...)
-
Mar 28, 2013 09:12AM
Biogen (BIIB) Target Raised to $215 at Jefferies after Tecfidera Approved with Favorable Label
-
Mar 25, 2013 08:40AM
Jefferies Maintains Bullish Stance on Biogen (BIIB) after AAN Meeting
-
Jan 3, 2013 09:41AM
StreetInsider.com Pre-Open Movers 01/03: (SPWR) (TASR) (GPS) Higher; (ALLT) (MLNX) (FDO) Lower (more...)
-
Sep 27, 2012 07:37AM
Jefferies Lifts Target on Biogen (BIIB) to $176, Hemophilia Data Adds To Valuation
-
Jul 25, 2012 10:05AM
Jefferies Maintains a 'Buy' on Biogen (BIIB) on Strong Q2; Adjusting Numbers
-
May 11, 2012 01:04PM
Arena Pharma (ARNA) Helps Lifts Biotech ETF (IBB)
-
May 2, 2012 02:47PM
Jefferies Increases Price Target in Biogen (BIIB)
-
Apr 23, 2012 08:06AM
Jefferies Maintains a 'Buy' on Biogen (BIIB); Favorable Gilenya Update
-
Apr 19, 2012 12:17PM
Streetinsider.com's Hot Lunchtime Reads 04/19: (SINA) (BIIB) (NFLX) (BAC) (SVVC)
-
Mar 15, 2012 08:25AM
Jefferies Maintains Bullish View on Biogen (BIIB) After Positive Hemophilia Pipeline Feedback
-
Oct 27, 2011 07:32AM
Jefferies Lifts Price Target on Biogen (BIIB), Strong CONFIRM Data Bodes Well For BG-12 Positioning
-
Oct 21, 2011 12:25PM
Jefferies Comments on Biogen (BIIB) Following Further BG12 Phase 3 DEFINE Analysis; Remains Bullish on Prospects in MS Use
-
Oct 5, 2011 09:44AM
Jefferies Comments on Biogen (BIIB), Sees Buying Opportunity
-
Sep 19, 2011 01:10PM
Jefferies Comments on Elan Corp (ELN), Making Moves in The Right Direction
-
Sep 9, 2011 11:07AM
Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
-
Aug 18, 2011 11:19AM
Notable Analyst Rating Changes 08/18: (SINA) (UDR) (BIIB) Upgraded; (NTAP) (GT) (IR) Downgraded
-
Aug 2, 2011 09:27AM
Jefferies Sees Failure of Phase 3 BRAVO Study as a Positive for Biogen (BIIB)
-
Jul 27, 2011 09:01AM
Jefferies Raises Price Target & Estimates on Biogen (BIIB), Strong Tysabri Sales
-
Jun 22, 2011 07:35AM
Jefferies Remains Bullish on Biogen Idec (BIIB) Following Meeting, MS Franchise Looks Strong
-
Jun 20, 2011 10:56AM
Notable Analyst Rating Changes 06/18: (MCP) (PCX) (MRVL) Upgraded; (SWKS) (CDXS) (RIMM) Downgraded
-
Jun 1, 2011 07:58AM
Jefferies Remains Positive on Biogen (BIIB) Following Dinner With MS Doctors
-
Apr 25, 2011 09:47AM
Jefferies Lifts Price Target On Biogen (BIIB) to $120 On BG-12 Success
-
Apr 18, 2011 07:21AM
Jefferies Raises Price Target & Estimates on Biogen (BIIB), Anticipates Stronger Tysabri and Avonex Sales
-
Apr 12, 2011 10:47AM
Notable Analyst Rating Changes 04/12: (LVLT) (EIX) (BIIB) Upgraded; (WMS) (AON) (CSX) Downgraded
-
Apr 12, 2011 08:13AM
Jefferies Raises Price Target on Biogen (BIIB), Positive BG-12 Data Twice Daily Dose Offers Strong Efficacy
-
Feb 2, 2011 08:53AM
Jefferies Raises Estimates on Biogen (BIIB), Maintains Buy Rating
-
Oct 27, 2010 08:57AM
Jefferies Notes Strong Underlying Demand for Biogen Idec's (BIIB) Tysabri, Ups Price Target
-
Oct 18, 2010 02:06PM
Jefferies Raises Price Target on Biogen Idec (BIIB), Sees 15% Upside
-
Apr 19, 2010 03:48PM
Trading Radar for 04/20: Apple (AAPL), Goldman Sachs (GS), Coca-Cola (KO), Johnson & Johnson (JNJ), Yahoo! (YHOO) Report
-
Jan 5, 2010 10:56AM
Notable Analyst Rating Changes 1/5: RSH, QCOM, BIIB, AXL, More Upgraded; CBY, V, BEXP, COG, CXO, More Downgraded
-
Nov 2, 2009 09:43AM
Jefferies & Co Upgrades Biogen Idec (BIIB) to Buy
-
Oct 23, 2009 10:53AM
Morning Movers 10/23: AMZN, CPWR, EPAY, ALGN, HWAY, SCSS, ACO Higher; ELN, SNV, CBRX, RMTR, STSA, DVAX Lower
-
Sep 2, 2009 10:14AM
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Jul 14, 2009 09:49AM
Notable Analyst Rating Changes 7/14: BK, UL, VMW, CNK, NILE Upgraded; MNKD, MAS, BKC, VOD Downgraded
-
Feb 9, 2009 10:21AM
David Moenning's Daily State of the Markets: 2/9